Budesonide - Medihealth (Northern) Ltd
Medihealth (Northern) Ltd
Description
Prophylaxis and treatment of allergic rhinitis and nasal polyps by intranasal administration
• Over 6 years: 256 mcg once daily, to be administered as 2 sprays into each nostril in the morning, reduce dose when control achieved. Alternatively, 128 mcg twice daily, to be administered as 1 spray into each nostril in the morning and in the evening, reduce dose when control achieved.
Prophylaxis of asthma by nebulised suspension
• Child 6 months–11 years: 125–500 mcg twice daily, dose to be adjusted as required. Maximum 2 mg per day.
• Over 12 years: initially 0.25–1 mg twice daily, dose to be adjusted as required. Maximum 2 mg per day.
Indications
For the prophylaxis of mild to moderate asthma.
For prophylaxis and treatment of allergic and vasomotor rhinitis, and nasal polyps.
Contraindications
Use cautiously in the case of renal or hepatic impairment.
Preparations Available
Spray
Sizes Available
Nasal spray
64 mcg, 120 doses
Nebuliser liquid
500 mcg/2 ml, 20 units
1 mg/2 ml, 20 units
More on: Corticosteroids , Budesonide , Nasal preparations , Corticosteroids